Display options
Cite
Wanji S, Tendongfor N, Esum M, et al. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon. Filaria J. 2005;4(1):2doi: 10.1186/1475-2883-4-2.
Wanji, S., Tendongfor, N., Esum, M., Yundze, S. S., Taylor, M. J., & Enyong, P. (2005). Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon. Filaria journal, 4(1), 2. https://doi.org/10.1186/1475-2883-4-2
Wanji, Samuel, et al. "Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon." Filaria journal vol. 4,1 (2005): 2. doi: https://doi.org/10.1186/1475-2883-4-2
Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon. Filaria J. 2005 Apr 07;4(1):2. doi: 10.1186/1475-2883-4-2. PMID: 15817124; PMCID: PMC1090603.
Copy Download .nbib Format: NLM
Share it on

Filaria J. 2005 Apr 07;4(1):2. doi: 10.1186/1475-2883-4-2.

Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.

Filaria journal

Samuel Wanji, Nicholas Tendongfor, Mathias Esum, Siker Sj Yundze, Mark J Taylor, Peter Enyong

Affiliations

  1. University of Buea, Faculty of Science, Department of Life Sciences, P,O, Box 63, Buea, Cameroon. [email protected].

PMID: 15817124 PMCID: PMC1090603 DOI: 10.1186/1475-2883-4-2

Abstract

BACKGROUND: Individuals with high microfilarial loads of Loa loa are at increased risk of neurologic serious adverse (SAE) events following ivermectin treatment against onchocerciasis. RAPLOA (Rapid Assessment Procedure for loiasis), a newly developed rapid assessment procedure for loiasis that relates the prevalence of key clinical manifestation of loiasis (history of eye worm) to the level of endemicity of the infection (prevalence of high intensity), is a very useful tool to identify areas at potential risk of L. loa post ivermectin treatment encephalopathy. In a perspective of treatment decision making in areas of co-endemicity of loiasis/onchocerciasis, it would be advantageous (both in time and cost savings) for national onchocerciasis control programmes to use RAPLOA and the Rapid epidemiologic assessment for onchocerciasis (REA), in combination in given surveys. Since each of the two rapid assessment tools have their own specificities, the workability of combining the two methods needed to be tested. METHODS: We worked in 10 communities of a forest area presumed co-endemic for loiasis and onchocerciasis in the North-West Province of Cameroon where the mass-treatment with ivermectin had not been carried out. A four-step approach was used and comprised: (i) generating data on the prevalence and intensity of loiasis and onchocerciasis in an area where such information is scarce; (ii) testing the relationship between the L. loa microfilaraemia prevalence and the RAPLOA prevalence, (iii) testing the relationship between the O. volvulus microfiladermia prevalence and the REA prevalence, (iv) testing the workability of combining RAPLOA/REA by study teams in which a single individual can perform the interview for RAPLOA and the nodule palpation for REA. RESULTS: The microfilaraemia prevalence of loiasis in communities ranged from 3.6% to 14.3%. 6 (0.61%) individuals had L. loa microfilarial loads above 8000 mf/ml but none of them attained 30,000 mf/ml, the threshold value above which the risk of developing neurologic SAE after ivermectin treatment is very high. None of the communities surveyed had RAPLOA prevalence above 40%. All the communities had microfiladermia prevalence above 60%. The microfiladermia results could be confirmed by the rapid epidemiologic method (nodule palpation), with all the 10 communities having REA prevalence above 20%. For the first time, this study has demonstrated that the two rapid assessment procedures for loiasis and onchocerciasis can be carried out simultaneously by a survey team, in which a single individual can administer the questionnaire for RAPLOA and perform the nodule palpation for REA. CONCLUSION: This study has: (i) Revealed that the Momo valley of the North West province of Cameroon is hyperendemic for onchocerciasis, but is of lower level of endemicity for L. loa. (ii) Confirmed the previous relationships established between RAPLOA and the L. loa microfilaraemia prevalence in one hand and between the REA and the O. volvulus microfiladermia prevalence in another hand (iii) Shown that RAPLOA and REA could be used simultaneously for the evaluation of loiasis and onchocerciasis endemicity in areas targeted by the African Programme for onchocerciasis Control for community-directed treatment with ivermectin (CDTI).

References

  1. Bull World Health Organ. 2002;80(11):852-8 - PubMed
  2. Med Microbiol Immunol. 2003 Feb;192(1):15-21 - PubMed
  3. Parasitol Today. 1996 Nov;12(11):448-50 - PubMed
  4. Am J Trop Med Hyg. 1998 Apr;58(4):461-9 - PubMed
  5. Ann Trop Med Parasitol. 1994 Oct;88(5):463-74 - PubMed
  6. Filaria J. 2003 Oct 24;2 Suppl 1:S7 - PubMed
  7. Filaria J. 2003 Oct 24;2 Suppl 1:S9 - PubMed
  8. Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):183-7 - PubMed
  9. Am J Trop Med Hyg. 2002 Jul;67(1):128-31 - PubMed
  10. Trop Med Parasitol. 1992 Dec;43(4):267-70 - PubMed
  11. Lancet. 1997 Jul 5;350(9070):18-22 - PubMed
  12. Ann Trop Med Parasitol. 2001 Jul;95(5):495-507 - PubMed
  13. Bull World Health Organ. 1967;37(4):629-50 - PubMed

Publication Types